Metabolomics of diabetes and cardiovascular disease

Metabolomics is an emerging field in biomarker discovery. Metabolites, which are small molecules with molecular weight less than 1.5kDa, have been found to be useful for early disease diagnosis and prediction for therapy, prognosis, and monitor treatment. Metabolites provide information on the real-time applications in clinical settings. Nevertheless, a number of challenges exist in the clinical settings. Despite the challenges, metabolomics is considered as a useful tool for biomarker and drug discovery. In this chapter, we will discuss the metabolites that have been identified as potential biomarker for cardiovascular disease and diabetes.